The Patent Finder

Terms ending in 2026

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,514,223Cross-Screening System and Methods for Detecting a Molecule Having Binding Affinity for a Target Molecule
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,763,245Methods and Compositions for Targeting Polyubiquitin
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,812,133ANTI-OX40L Antibodies and Methods Using Same
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 8,906,648Recombinant Production of Vascular Endothelial Growth Factor
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited